X4 Pharmaceuticals (XFOR) executive compensation, 2026 proxy

Paula Ragan, Ph.D., Former President and Chief Executive Officer, was paid $2.6M in 2025, up 23% from $2.1M the year before.

Filed
March 20, 2026
Annual meeting
May 11, 2026
Pay year
2025
Named executives
4
CEO total pay
$2.6M+23% vs prior year
CEO pay in equity
41%$1.1M in awards
Former CEO Total Pay
$2,640,569For fiscal year 2025
Executive Chairman Total Pay
$6,705,205Adam R. Craig
President and COO Total Pay
$6,667,487John Volpone
CFO Total Pay
$4,599,266David Kirske

How Ph.D. was paid

$2.6M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary16%Stock awards41%All other compensation43%

Named executive officers

ExecutiveTotal
Adam R. Craig, M.D., Ph.D., M.B.A.Executive Chairman$6,705,205
Paula Ragan, Ph.D.Former President and Chief Executive Officer$2,640,569
John Volpone, M.B.A.President and Chief Operating Officer$6,667,487
David KirskeChief Financial Officer, Treasurer and Corporate Secretary$4,599,266

What changed and why

  • $2.6MPaula Ragan served as President and CEO until August 11, 2025, receiving total compensation of $2,640,569.
  • $6.7MAdam R. Craig was appointed Executive Chairman on August 11, 2025, with total compensation of $6,705,205.
  • $6.7MJohn Volpone was appointed President and Chief Operating Officer, earning total compensation of $6,667,487.
  • $4.6MDavid Kirske joined as Chief Financial Officer and received total compensation of $4,599,266.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.